The global Immortalized Cell Line Market is spreading out due to the demand generated by the biotech and pharmaceutical industries. Immortalized cells do exist naturally, but in the form of a tumorous cell, however, it can be created artificially. Technological advancements enabled researchers to immortalize and culture these cells for several generations to ensure quality experiments. Some of the prominent cells that have been immortalized are HepaRD and Hep G2. The cells have made a significant contribution in the field of drug discovery and other researches to develop treatment strategies for various diseases. The global immortalized cell line market is expecting a robust growth by 9.30% CAGR during the forecast period (2018-2023), and the market can easily cross a total valuation of USD 4,100 million, proclaims Market Research Future (MRFR) in a published report. The report further includes segmentations, detailed analysis of the competitive landscape, expert tips, and factors that can influence the market considerably.
Among the major factors, the global immortalized cell line market is gaining foothold owing to researches conducted by the biotech and pharmaceutical companies to deliver better drugs. Researches regarding cancer treatment and organ transplants are promoting regional markets. The effectiveness and efficiency of the research methods have made it an essential part of the cancer cure determination. The global immortalized cell line market is poised to become even more lucrative in the coming years as various research sectors regarding drug development are diversifying tests to develop drugs for other diseases as well.
However, stringent regulatory and licensing norms are with high initial investment can detract the immortalized cell line market from having the desired growth during the forecast period. The initial culture laboratory for such researches incurs a high cost. But governments are planning on promoting such researches for better immortalized cell line market prospect.
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/751
The report published by MRFR on the immortalized cell line market can be segmented by the method, application, and end-user.
Based on the method, the immortalized cell line market can be segmented into virus induction, hTERT expression, inactivation of tumor suppression genes, and others. Virus induction segment tops the market segment.
By application, the immortalized cell line market comprises diagnostics, vaccine production, drug discovery, tissue engineering and regenerative medicine, and others. Vaccine production segment is estimated to gain the fastest CAGR during the forecast period due to the growth in the wide applications in vaccine productions.
By end-user, the immortalized cell line market can be segmented into pharmaceutical and biopharmaceutical companies, research laboratories, Contract Research Organizations (CROs), and others. The pharmaceutical and biopharmaceutical companies segment is to retain its premier position during the forecast period.
Geographical analysis of the global immortalized cell line market includes namely the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas market is leading the chart with the maximum market share of the revenue. The region has the superior infrastructure and invests substantial amount for research and development purposes. Owing to these two major factors, the region is enjoying substantial growth.
Europe is also spending heavily on better drug development. The region has several companies that are impacting the global market with mergers and acquisitions, and also by developing new drugs. Relatively higher customer awareness in the Americas and Europe are promoting the market.
The APAC market is gaining more as many market titans are looking at the region as a very good market investment plan owing to cost-effective resources.
Prominent players profiled in the immortalized cell line market report are Lonza Group, AG, Thermo Fisher Scientific, Merck KGaA, ATCC (American Type Culture Collection Inc.), Valneva, Sartorius AG, Wuxi App Tec, European Collection of Authenticated Cell Cultures (ECACC), Selexis SA, and Corning Incorporated.
In November 2018, an article published in the National Institute for Environmental Studies claimed that researchers had found a new method to extend the lifespan of Okinawa Rail, which has become endangered. For researches, its cell was needed to be immortalized, but the traditional method failed. The researchers then came up with the co-expression of mutant CDK4, Cyclin D and TERT (K4DT method) in the avian cells which although failed to immortalize it but enhanced the lifespan considerably. This new way can become a backup method for researchers in case the original does not produce the required result.